Mesenchymal Stem Cell Control of Metastatic Prostate Cancer Cell Evolution and Therapy Resistance in the Bone Microenvironment
Technical Report,15 Aug 2018,14 Aug 2019
H. Lee Moffitt Cancer Center and Research Institute Tampa United States
Pagination or Media Count:
The goal of this proposal is to examine the impact of interleukin-28 in promoting the resistance of prostate cancer cells in bone. In the first year of this award we have made significant progress in Aim 1 while Aim 2 and Aim 3 are underway. Resources for Aim 4 are currently being coordinated. Overall, we are on track with the stated milestonesobjectives.
- Medicine and Medical Research